BIOVIE, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 27
Rang # Quantité totale PI 53 520
Note d'activité PI 2,2/5.0    22
Rang # Activité PI 36 845
Symbole boursier BIVI (nasdaq)
ISIN US09074F2074
Capitalisation 53.30M  (USD)
Industrie Biotechnology
Secteur Healthcare

Brevets

Marques

18 0
2 0
7 0
0
 
Dernier brevet 2024 - Assay and methods for drug disco...
Premier brevet 1988 - Agents for the arrest and therap...

Derniers inventions, produits et services

2024 Invention Treatment of ascites. A method for treating ascites patients by administering the peptide drug t...
Invention Assay and methods for drug discovery. Disclosed herein are methods for assaying a potential drug ...
2023 Invention Compositions for treatment of neurodegenerative conditions. Disclosed herein is a pharmaceutical...
Invention Methods for the treatment of biological aging. RSRSRRSS-triol, including solid states thereof. Al...
Invention Methods for the treatment of mild cognitive impairment. RSSRRSS-triol, including solid states the...
Invention Methods of treating disease with terlipressin. Provided are methods of treating a disease with ar...
Invention Methods of treating disease with terlipressin. Provided are methods of treating a disease with a...
2022 Invention Compositions for treatment of neurodegenerative conditions. Disclosed herein is a pharmaceutical ...
Invention Compositions for treatment of neurodegenerative conditions. RSRSRRSS-triol. Also disclosed herein...
Invention Formulations of terlipressin. The disclosure provides pharmaceutical compositions comprising ter...
2021 Invention Crystalline solvate forms of a pharmaceutical. Described herein are solid state 17α-ethynylandro...
2020 Invention Formulations of terlipressin. The disclosure provides pharmaceutical compositions comprising terl...
2019 Invention Crystalline solvate forms of a pharmaceutical. Described herein are solid state 17α-ethynylandros...
Invention Treatment of ascites. A method for treating ascites patients by administering the peptide drug te...
2016 Invention Crystalline solvate forms of a pharmaceutical. The invention provides and describes solid state 1...
2015 Invention Method for preparing substituted 3,7-dihydroxy steroids. The invention relates to processes for p...
2014 Invention Treatment methods using pharmaceutical solid state forms. The invention provides and describes so...
Invention Crystalline anhydrate forms of a pharmaceutical. The invention provides and describes solid state...
2013 Invention Steroids having 7-oxygen and 17-heteroaryl substitution-3. The invention relates to the use of co...
Invention Steroids having 7-oxygen and 17-heteroaryl substitution-2. The invention relates to the use of co...
Invention Methods of preparing pharmaceutical solid state forms. The invention provides and describes solid...
Invention Pharmaceutical solid state forms-2. The invention provides and describes solid state 17α-ethynyl...
Invention Treatment methods using pharmaceutical solid state forms. The invention provides and describes s...
Invention Treatment of ocular diseases. The invention relates to methods to use 17α-ethynylandrost-5-ene-3...
Invention Drug identification method. The invention relates to a method to identify compounds exert a tran...
2012 Invention Methods for preparing 17-alkynyl-7-hydroxy steroids and related compounds-2. The invention relate...
Invention Crystalline anhydrate forms of a pharmaceutical. The invention provides and describes solid stat...
2011 Invention Steroid tetrol solid state forms - 2. The invention relates to solid state forms of androst-5-en...
Invention Steroid tetrol solid state forms. The invention relates to solid state forms of androst-5-ene-3β...
Invention Methods and compounds for preparing 3alpha-oxygen substituted steroids. The invention relates to...
Invention Steroid compounds and treatment methods. The invention provides methods to treating conditions su...
Invention Screening and treatment method. The invention provides a method to analyze an effect of a biolog...
Invention 11-aza, 11-thia and 11-oxa sterol compounds and compositions. The invention provides compositions...
Invention 15-thia steroid compounds and compositions. The invention relates to the use of compounds to tre...
Invention Steroids having 7-oxgen and 17-heteroaryl substitution. The invention relates to the use of compo...
Invention Unsaturated steroid compounds. The invention relates to methods to manipulate stem cells in vivo ...
2010 Invention Drug product and process for making. The invention provides a drug product for treating radiatio...
Invention Steroid compounds and formulations. The invention provides methods to treating conditions such as...
Invention Anticancer compounds and screening method. The invention provides a method to identify or charac...
Invention Unsaturated steroid compounds. The instant invention provides potent antiandrogen compounds, suc...
Invention Cancer treatment methods. The invention provides methods to treating conditions such as prostate ...
Invention Patient populations and treatment methods. The invention provides 17α-ethynylandrost-5-ene-3β,7β...
2009 Invention Pharmaceutical compositions-4. The invention provides compositions comprising formula 1 steroids,...
Invention 15-oxa-steroid compounds. The invention relates to the use of compounds to treat a number of cond...
Invention Compounds and compositions. The invention provides compositions comprising formula 1 steroids, e....